| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 1e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 4e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |